Cargando…

Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases

BACKGROUND: Anti-angiogenic therapy with bevacizumab (an anti-vascular endothelial growth factor (VEGF) antibody) predominantly targets immature blood vessels. Bevacizumab has shown a survival benefit in non-small cell lung carcinoma (NSCLC) and has recently been demonstrated to be safe in patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jubb, A M, Cesario, A, Ferguson, M, Congedo, M T, Gatter, K C, Lococo, F, Mulè, A, Pezzella, F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111192/ https://www.ncbi.nlm.nih.gov/pubmed/21540863 http://dx.doi.org/10.1038/bjc.2011.147

Ejemplares similares

Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas
por: Passalidou, E, et al.
Publicado: (2002)

Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?
por: Donnem, Tom, et al.
Publicado: (2013)

Vascular patterns in reactive lymphoid tissue and in non-Hodgkin's lymphoma
por: Passalidou, E, et al.
Publicado: (2003)

Blood vessels and cancer much more than just angiogenesis
por: Pezzella, F, et al.
Publicado: (2015)

Is nonangiogenesis a novel pathway for cancer progression? A study using 3-dimensional tumour reconstructions
por: Adighibe, O, et al.
Publicado: (2006)

The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases
por: Cohen, Stacey A., et al.
Publicado: (2017)

Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival
por: Giatromanolaki, A, et al.
Publicado: (2001)

Immunocytochemistry in the detection of bone marrow metastases in patients with primary lung cancer.
por: Frew, A. J., et al.
Publicado: (1986)

Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
por: Korkolopoulou, P., et al.
Publicado: (1996)

Genome-wide aberrant methylation in primary metastatic UM and their matched metastases
por: Smit, Kyra N., et al.
Publicado: (2022)

Twenty years after: the beautiful hypothesis and the ugly facts
por: Pezzella, Francesco, et al.
Publicado: (2016)

bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer.
por: Leek, R. D., et al.
Publicado: (1994)

Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma.
por: Pezzella, F., et al.
Publicado: (1992)

Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer
por: Kato, T, et al.
Publicado: (2007)

Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes
por: Thomson, A H, et al.
Publicado: (2016)

Anti-angiogenic therapies in brain metastases
por: Berghoff, Anna S., et al.
Publicado: (2018)

Management of single pulmonary metastases from colorectal cancer: State of the art
por: Chiappetta, Marco, et al.
Publicado: (2022)

Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer
por: Jubb, A M, et al.
Publicado: (2009)

Clinical significance of B7-H4 expression in matched non-small cell lung cancer brain metastases and primary tumors
por: Li, Zhen-ye, et al.
Publicado: (2013)

Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature
por: Tsakonas, Georgios, et al.
Publicado: (2022)

Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases
por: Steindl, A., et al.
Publicado: (2021)

Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastases
por: Manson, Quirine F., et al.
Publicado: (2018)

Immune checkpoint inhibition in patients treated with stereotactic radiation for brain metastases
por: Kowalski, Emily S., et al.
Publicado: (2020)

Highly prevalent Russian HIV-1 V3-loop sequence variants are susceptible to maraviroc
por: Lewis, ME, et al.
Publicado: (2021)

Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer
por: Lecharpentier, A, et al.
Publicado: (2011)

How well did our students match? A peer-validated quantitative assessment of medical school match success: the match quality score
por: Chakraborti, Chayan, et al.
Publicado: (2019)

Perilesional edema in brain metastases: potential causes and implications for treatment with immune therapy
por: Tran, Thuy T., et al.
Publicado: (2019)

Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in Colorectal Liver Metastases (CRLM): Looking Beyond the Tumor Margin
por: Siriwardana, Pulathis N., et al.
Publicado: (2016)

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
por: O'Byrne, K J, et al.
Publicado: (2000)

Risk of brain metastases in T1–3N0 NSCLC: a population-based analysis
por: Milano, Michael T, et al.
Publicado: (2020)

Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases
por: Weiss, Sarah A., et al.
Publicado: (2020)

Treatment of locally advanced rectal cancer and synchronous liver metastases: multicentre comparison of two treatment strategies
por: van Rees, Jan M, et al.
Publicado: (2023)

Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden
por: Frisk, G, et al.
Publicado: (2012)

Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors
por: Zhu, Li, et al.
Publicado: (2019)

Pathway-level mutation analysis in primary high-grade serous ovarian cancer and matched brain metastases
por: Duchnowska, Renata, et al.
Publicado: (2022)

HER2 gene status in primary breast cancers and matched distant metastases
por: Tapia, Coya, et al.
Publicado: (2007)

Heterogeneity of neoantigen landscape between primary lesions and their matched metastases in lung cancer
por: Jiang, Tao, et al.
Publicado: (2020)

Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours
por: Chen, Bo, et al.
Publicado: (2021)

Mystery behind the match: an undergraduate medical education–graduate medical education collaborative approach to understanding match goals and outcomes
por: Nagler, Alisa, et al.
Publicado: (2016)

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients
por: Knijn, N, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2jm4r1cr8krj04rk3kc9p7pa6d